Golden Meditech’s Associate, Cellenkos, Focuses on the Development of Cell-theray for Treatment of COVID-19 Mediated Acute Respiratory Distress Syndrome (CoV-ARDS)
- Wednesday, March 18, 2020, 7:10
- Finance
- Add a comment
HONG KONG, March 18, 2020 /PRNewswire/ — Golden Meditech Holdings Limited (SEHK stock code: 00801) (“Golden Meditech”), a leading integrated healthcare enterprise in China, announced that its associate, Cellenkos, Inc. (“Cellenkos”) has submitted a clinical development proposal to the…
About the Author
adminasapcorp has written 41842 stories on this site.